These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 2863787

  • 1. [Therapeutic use of beta blockers in gastroenterology. Gastrointestinal iatrogenic diseases caused by beta blocker use].
    De Simone M, Leonardi C, Carbonetti M, Mazzetti di Pietralata M.
    Minerva Dietol Gastroenterol; 1985; 31(2):245-52. PubMed ID: 2863787
    [No Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
    Frishman W, Silverman R, Strom J, Elkayam U, Sonnenblick E.
    Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744
    [No Abstract] [Full Text] [Related]

  • 3. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A, Branchetti A, Barella PA.
    G Ital Dermatol Venereol; 1983 Aug; 118(6):341-8. PubMed ID: 6143722
    [No Abstract] [Full Text] [Related]

  • 4. Beta blockers in hypertension.
    Zacharias FJ.
    Brux Med; 1973 Nov; Spec No(0):111-46. PubMed ID: 4154127
    [No Abstract] [Full Text] [Related]

  • 5. [Beta-blockers in gastroenterology and hepatology].
    Malè PJ.
    Rev Med Suisse Romande; 1984 Mar; 104(3):203-6. PubMed ID: 6144157
    [No Abstract] [Full Text] [Related]

  • 6. [Study of the respiratory tolerance of adrenolytic beta-blockers in the asthmatic].
    Hugues FC, Julien D, Munera Y, Marche J.
    Nouv Presse Med; 1978 Sep 20; 7(31):2711-5. PubMed ID: 30948
    [No Abstract] [Full Text] [Related]

  • 7. [Beta blocking agents during pregnancy].
    Tchobroutsky C.
    Arch Fr Pediatr; 1978 May 20; 35(5):571-7. PubMed ID: 28101
    [No Abstract] [Full Text] [Related]

  • 8. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM, Polena S, Solinas A, Sanghvi K, Gintautas J.
    Proc West Pharmacol Soc; 2003 May 20; 46():125-6. PubMed ID: 14699906
    [No Abstract] [Full Text] [Related]

  • 9. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E, Anson O, Neumann L.
    Am J Hypertens; 1996 Dec 20; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [Abstract] [Full Text] [Related]

  • 10. [The importance of the myocardial adrenoreceptors and their therapeutic significance].
    Brodde OE.
    Klin Anasthesiol Intensivther; 1991 Dec 20; 41():72-80. PubMed ID: 1685756
    [No Abstract] [Full Text] [Related]

  • 11. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
    Sontheimer D, Hitchcock K, Saseen J.
    J Fam Pract; 2007 Apr 20; 56(4):312-4. PubMed ID: 17403332
    [No Abstract] [Full Text] [Related]

  • 12. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
    Dotzer F, Gromer H.
    Fortschr Med; 1993 Aug 30; 111(24):382-4. PubMed ID: 8104853
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Adrenergic beta receptor blockaders].
    Naess K.
    Tidsskr Nor Laegeforen; 1975 Feb 28; 95(6):380-3. PubMed ID: 235805
    [No Abstract] [Full Text] [Related]

  • 15. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs.
    Adams HR.
    J Am Vet Med Assoc; 1984 Nov 01; 185(9):966-74. PubMed ID: 6150925
    [Abstract] [Full Text] [Related]

  • 16. Managing angina with beta blockers.
    Segal BL, Kotler MN, Iskandrian AS.
    Geriatrics; 1982 Oct 01; 37(10):69-72, 76. PubMed ID: 6126421
    [No Abstract] [Full Text] [Related]

  • 17. Comparative tolerability of labetalol versus propranolol, atenolol, pindolol, metoprolol, and nadolol.
    Burris JF, Goldstein J, Zager PG, Sutton JM, Sirgo MA, Plachetka JR.
    J Clin Hypertens; 1986 Sep 01; 2(3):285-93. PubMed ID: 2878065
    [Abstract] [Full Text] [Related]

  • 18. [Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
    Krämer B, Kübler W.
    Dtsch Med Wochenschr; 1984 Mar 23; 109(12):465-71. PubMed ID: 6142815
    [No Abstract] [Full Text] [Related]

  • 19. Beta-blockers in cirrhosis: friend and foe?
    Wong F, Salerno F.
    Hepatology; 2010 Sep 23; 52(3):811-3. PubMed ID: 20812354
    [No Abstract] [Full Text] [Related]

  • 20. The use of beta blockers for the reduction of mortality after myocardial infarction.
    Hampton JR.
    Eur Heart J; 1981 Aug 23; 2(4):259-68. PubMed ID: 6117465
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.